Dongwoon Anatech News Today

GAAP Net Income of $19.7 million or $0.60 per diluted share Non-GAAP Net Income of $14.8 million or $0.45 per diluted share Declares Quarterly Dividend ... | February 22, 2023

/PRNewswire/ -- According to Technavio, the global haptics market size is expected to grow by USD 7,523.18 million from 2022 to 2027. The market is estimated...

Global Haptics Market 2023-2027 The analyst has been monitoring the haptics market and it is poised to grow by $7,523. 18 mn during 2023-2027, accelerating...

/PRNewswire/ -- Haptics is a tactile feedback technology that reinvents the sense of touch by applying forces, vibrations, or motions to the user. Through this...

(Credit: Dongwoon Anatech) South Korean fabless manufacturer Dongwoon Anatech is seeking the approval of both the US and Korean Food and Drug Administration for the commercial rollout of its saliva-based glucose monitoring device after completing its first clinical trial in December. WHAT IT DOES The sugar monitoring device called D-SaLife, a product of six years of research and development, makes use of microcurrent control technology in determining the glucose level present in a person’s s...